Study of Optimal Treatment Strategies for Ventricular Tachycardia in Adults with Cardiomyopathy Using Implantable Defibrillators

What this Trial Is About

Ventricular tachycardia VT is a serious heart rhythm problem that can lead to sudden cardiac death and other severe complications. This study focuses on patients with cardiomyopathy who have experienced VT, aiming to find the best treatment approaches to improve long-term outcomes. Researchers will also examine how VT affects patients in real-world settings, including treatment safety, effectiveness, adherence to guidelines, and cost-effectiveness. The study follows patients with ischemic and non-ischemic cardiomyopathy from their first VT event for at least three years or until death. Researchers will collect data remotely from implantable cardiac defibrillators ICDs and review these events carefully without knowing the patients treatment or center. The goal is to identify the most effective treatment sequences to maximize event-free survival. Participants will be monitored through ICD remote tracking and clinical evaluations over time. The main outcome is to determine the best treatment plan for each patient over five years. The study also looks at how treatments are used in practice and differences in outcomes between men and women. Participants will be followed closely for safety and treatment results throughout the study period.

END - VT Cohort Study